Price (delayed)
$10.21
Market cap
$651.35M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.28
Enterprise value
$823.93M
Avid Bioservices is a dedicated contract development and manufacturing organization (CDMO) focused on development and CGMP manufacturing of biopharmaceutical drug substances derived from mammalian cell culture. The company provides a
There are no recent dividends present for CDMO.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.